Supporting this concept, recent studies have shown that downregulation of BACE1 expression through epigenome editing in AD animal models can attenuate cognitive deficits and reduce Aβ plaques accumulation (Han et al. 2024). Here, BACE1 is linked to Alzheimer disease.